Halozyme Therapeutics shares owned by Goldstein Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Goldstein Advisors
from 13F filings
Historical chart of Goldstein Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Goldstein Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Goldstein Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $15k | 14k | 1.08 |
| 2025-06-30 | $14k | 14k | 0.99 |
| 2025-03-31 | $15k | 14k | 1.05 |
| 2024-12-31 | $13k | 14k | 0.95 |
| 2024-09-30 | $14k | 14k | 1.00 |
| 2024-06-30 | $13k | 14k | 0.95 |
| 2024-03-31 | $17k | 19k | 0.88 |
| 2023-12-31 | $2.1M | 24k | 86.14 |
| 2023-09-30 | $20k | 24k | 0.84 |
| 2023-06-30 | $20k | 24k | 0.83 |